PG
ABMD

PEAK6 Group’s Abiomed Inc ABMD Stock Holding History

PEAK6 Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$31.9M Sell
78,000
-13,300
-15% -$4.82M 0.14% 123
2018
Q1 		$26.6M Buy
91,300
+35,700
+64% +$9.05M 0.12% 159
2017
Q4 		$10.4M Buy
55,600
+40,500
+268% +$7.56M 0.05% 448
2017
Q3 		$2.55M Buy
15,100
+9,900
+190% +$1.5M 0.01% 1195
2017
Q2 		$745K Buy
5,200
+4,200
+420% +$564K ﹤0.01% 2168
2017
Q1 		$125K Sell
1,000
-10,600
-91% -$1.23M ﹤0.01% 3439
2016
Q4 		$1.31M Sell
11,600
-37,100
-76% -$4.3M 0.01% 1641
2016
Q3 		$6.26M Buy
48,700
+25,800
+113% +$3.09M 0.05% 569
2016
Q2 		$2.5M Buy
22,900
+7,200
+46% +$716K 0.02% 1080
2016
Q1 		$1.49M Buy
15,700
+5,700
+57% +$481K 0.01% 1364
2015
Q4 		$903K Buy
10,000
+2,400
+32% +$204K 0.01% 2028
2015
Q3 		$705K Buy
7,600
+2,100
+38% +$185K ﹤0.01% 2556
2015
Q2 		$362K Buy
+5,500
New +$365K ﹤0.01% 3113

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PEAK6 Group's ABMD Position: Q2 2016 in Review

PEAK6 Group sold out of Abiomed Inc (ABMD) in Q2 2016, closing a stake of 2,907 shares — an estimated $289K sold.

PEAK6 Group first reported a position in ABMD in Q2 2015 and held it in 3 quarters. The position peaked at $370K in Q2 2015. 297 funds tracked by Wall St. Rank hold ABMD as of Q2 2016.

  • PEAK6 Group reported no remaining Abiomed Inc position as of Q2 2016 after selling out during the quarter.
  • PEAK6 Group sold 2,907 Abiomed Inc shares in Q2 2016, an estimated $289K.
  • PEAK6 Group first reported a position in Abiomed Inc in Q2 2015 and held it in 3 quarters.
  • PEAK6 Group's Abiomed Inc position peaked at $370K in Q2 2015.
  • 297 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2016.

Based on PEAK6 Group's 13F filing for Q2 2016, filed 10 Aug 2016.